GSK, Pfizer combining efforts to boost role in AIDS market

04/16/2009 | Bloomberg

GlaxoSmithKline and Pfizer are forming a company to combine their HIV-drug businesses, hoping to gain a nearly 20% share of the $12.3 billion AIDS market that Gilead Sciences dominates. GSK will take control of 85% of the firm, which will own 11 medicines on the market and six experimental treatments.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY